“We’ve successfully treated over 100,000 patients”
The Prolieve® Transurethral ThermoDilatation™ Therapy (TUTD™) offers a unique “Thermodilatation” treatment for symptoms of enlarged prostate, also known as benign prostatic hyperplasia (BPH). Prolieve® is the only patented and FDA approved Thermodilatation device on the market. Prolieve® is a combination therapy simultaneously using Focused Microwave Heating together with Pressurized Balloon Dilatation therapy. The unique combination treatment is a 45-minute, in-office, outpatient procedure which is performed and well-tolerated under local anesthesia. Patients do not require a post treatment Foley catheter about 90% of the time in contrast to the other invasive or even minimally invasive treatment options. Additionally, the majority of patients experience significant and immediate relief of their BPH symptoms.
The 5-year follow-up FDA Post Approval Study of Prolieve® confirms long-term safety, efficacy and durability with improved lower urinary tract symptoms, urinary flow rate, quality of life, and minimal sexual side effects when compared to an untreated age-matched male population. In addition, in the Post Approval Study, Prolieve® Therapy was demonstrated to be able to stabilize serum PSA and Prostate Sizes during the entire 5 years of follow-up.